Recommended Conferences

Cancer-Treatment and Therapeutics

New York, USA
Related Subjects
 

Evaluation, treatment and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline

Author(s): Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al.

Abstract

Objective:

The objective was to provide guidelines to clinicians for the evaluation, treatment, and prevention of vitamin D deficiency with an emphasis on the care of patients who are at risk for deficiency.

Participants:

The Task Force was composed of a Chair, six additional experts, and a methodologist. The Task Force received no corporate funding or remuneration.

Consensus Process:

Consensus was guided by systematic reviews of evidence and discussions during several conference calls and e-mail communications. The draft prepared by the Task Force was reviewed successively by The Endocrine Society's Clinical Guidelines Subcommittee, Clinical Affairs Core Committee, and cosponsoring associations, and it was posted on The Endocrine Society web site for member review. At each stage of review, the Task Force received written comments and incorporated needed changes.

Conclusions:

Considering that vitamin D deficiency is very common in all age groups and that few foods contain vitamin D, the Task Force recommended supplementation at suggested daily intake and tolerable upper limit levels, depending on age and clinical circumstances. The Task Force also suggested the measurement of serum 25-hydroxyvitamin D level by a reliable assay as the initial diagnostic test in patients at risk for deficiency. Treatment with either vitamin D2 or vitamin D3 was recommended for deficient patients. At the present time, there is not sufficient evidence to recommend screening individuals who are not at risk for deficiency or to prescribe vitamin D to attain the noncalcemic benefit for cardiovascular protection.

 

Similar Articles

Vitamin D

Author(s): Dusso A, Brown A, Slatopolsky E

Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study

Author(s): Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, et al.

Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study

Author(s): Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, Ruiz JC

Vitamin D status in patients with chronic plaque psoriasis

Author(s): Gisondi P, Rossini M, Di Cesare A, Idolazzi L, Farina S, et al.

Immunocytochemical localization of the 1,25-dihydroxyvitamin-D3 receptor in target cells

Author(s): Clemens TL, Garrett KP, Zhou XY, Pike JW, Haussler MR, et al.

Vitamin D and autoimmune rheumatologic disorders

Author(s): Plajo CF, Lopez-Benitez JM, Miller LC

Influence of narrowband UVB phototherapy on vitamin D and folate status

Author(s): Cicarma E, Mork C, Porojnicu AC, Juzeniene A, Tam TT, et al.

The effect of narrowband UV-B treatment for psoriasis on vitamin D status during wintertime in Ireland

Author(s): Ryan C, Moran B, McKenna MJ, Murray BF, Brady J, et al.

Narrowband ultraviolet B treatment boosts serum 25-hydroxyvitamin D in patients with psoriasis on oral vitamin D supplementation

Author(s): Ala-houhala MJ, Karppinen TT, Vahavihu K, Kautiainen H, Dombrowski Y, et al.

Vitamin D status in psoriasis patients during different treatments with phototherapy

Author(s): Osmancevic A, Landin-Wilhelmsen K, Larko O, Krogstad AL

Serum levels of 25-hydroxy vitamin D in psoriatic patients

Author(s): Zuchi MF, Azevedo Pde O, Tanaka AA, Schmitt JV, Martins LE

Serum 25- OH Vitamin D Level in Psoriatic Patients and Comparison With Control Subjects

Author(s): Maleki M, Nahidi Y, Azizahari S, Meibodi NT, Hadianfar A

Vitamin D receptor polymorphism is associated with psoriasis

Author(s): Park BS, Park JS, Lee DY, Youn JI, Kim IG

Vitamin D receptor polymorphisms and diseases

Author(s): Valdivielso JM, Fernandez E